Genetic Analysis AS (NGM:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.9100
+0.0600 (7.06%)
At close: Jul 11, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 57.22 million as of July 25, 2025. Its market cap has increased by 102.60% in one year.
Market Cap
57.22M
Enterprise Value
54.56M
Revenue
19.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.91
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 57.22M, a decrease of -75.70%. That is a compound annual growth rate of -31.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 57.22M | 133.96% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 95.48B |
| Sectra AB | 65.66B |
| Getinge AB | 50.21B |
| Asker Healthcare Group AB | 41.64B |
| Medicover AB | 37.22B |
| Camurus AB | 35.30B |
| AddLife AB | 22.35B |
| Vimian Group AB | 20.59B |